Heidi A Hanson1, Ross E Anderson2, Kenneth I Aston3, Douglas T Carrell3, Ken R Smith4, James M Hotaling5. 1. Department of Family and Preventive Medicine, University of Utah, Salt Lake City, Utah; Population Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. Electronic address: heidi.hanson@hci.utah.edu. 2. Division of Urology, Department of Surgery, University of Utah, Salt Lake City, Utah. 3. Division of Urology, Department of Surgery, University of Utah, Salt Lake City, Utah; Center for Men's Health and Reconstructive Surgery, University of Utah, Salt Lake City, Utah; Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah. 4. Population Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; Department of Family and Consumer Studies and Population Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 5. Center for Men's Health and Reconstructive Surgery, University of Utah, Salt Lake City, Utah.
Abstract
OBJECTIVE: To further understand the association between semen quality and cancer risk by means of well defined semen parameters. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): A total of 20,433 men who underwent semen analysis (SA) and a sample of 20,433 fertile control subjects matched by age and birth year. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Risk of all cancers as well as site-specific results for prostate cancer, testicular cancer, and melanoma. RESULT(S): Compared with fertile men, men with SA had an increased risk of testicular cancer (hazard rate [HR] 3.3). When the characterization of infertility was refined using individual semen parameters, we found that oligozoospermic men had an increased risk of cancer compared with fertile control subjects. This association was particularly strong for testicular cancer, with increased risk in men with oligozoospermia based on concentration (HR 11.9) and on sperm count (HR 10.3). Men in the in the lowest quartile of motility (HR 4.1), viability (HR 6.6), morphology (HR 4.2), or total motile count (HR 6.9) had higher risk of testicular cancer compared with fertile men. Men with sperm concentration and count in the 90th percentiles of the distribution (≥178 and ≥579 × 10(6)/mL, respectively), as well as total motile count, had an increased risk of melanoma (HRs 2.1, 2.7, and 2.0, respectively). We found no differences in cancer risk between azoospermic and fertile men. CONCLUSION(S): Men with SA had an increased risk of testicular cancer which varied by semen quality. Unlike earlier work, we did not find an association between azoospermia and increased cancer risk. Published by Elsevier Inc.
OBJECTIVE: To further understand the association between semen quality and cancer risk by means of well defined semen parameters. DESIGN: Retrospective cohort study. SETTING: Not applicable. PATIENT(S): A total of 20,433 men who underwent semen analysis (SA) and a sample of 20,433 fertile control subjects matched by age and birth year. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Risk of all cancers as well as site-specific results for prostate cancer, testicular cancer, and melanoma. RESULT(S): Compared with fertile men, men with SA had an increased risk of testicular cancer (hazard rate [HR] 3.3). When the characterization of infertility was refined using individual semen parameters, we found that oligozoospermic men had an increased risk of cancer compared with fertile control subjects. This association was particularly strong for testicular cancer, with increased risk in men with oligozoospermia based on concentration (HR 11.9) and on sperm count (HR 10.3). Men in the in the lowest quartile of motility (HR 4.1), viability (HR 6.6), morphology (HR 4.2), or total motile count (HR 6.9) had higher risk of testicular cancer compared with fertile men. Men with sperm concentration and count in the 90th percentiles of the distribution (≥178 and ≥579 × 10(6)/mL, respectively), as well as total motile count, had an increased risk of melanoma (HRs 2.1, 2.7, and 2.0, respectively). We found no differences in cancer risk between azoospermic and fertile men. CONCLUSION(S): Men with SA had an increased risk of testicular cancer which varied by semen quality. Unlike earlier work, we did not find an association between azoospermia and increased cancer risk. Published by Elsevier Inc.
Entities:
Keywords:
Semen quality; cancer; infertility; testicular cancer
Authors: N Jewel Samadder; Karen Curtin; Thérèse M F Tuohy; Kerry G Rowe; Geraldine P Mineau; Ken R Smith; Richard Pimentel; Jathine Wong; Ken Boucher; Randall W Burt Journal: Gastroenterology Date: 2014-07-17 Impact factor: 22.682
Authors: Mark H Greene; Christian P Kratz; Phuong L Mai; Christine Mueller; June A Peters; Gennady Bratslavsky; Alex Ling; Peter M Choyke; Ahalya Premkumar; Janet Bracci; Rissah J Watkins; Mary Lou McMaster; Larissa A Korde Journal: Endocr Relat Cancer Date: 2010-03-08 Impact factor: 5.678
Authors: Melissa M Smarr; Katherine J Sapra; Alison Gemmill; Linda G Kahn; Lauren A Wise; Courtney D Lynch; Pam Factor-Litvak; Sunni L Mumford; Niels E Skakkebaek; Rémy Slama; Danelle T Lobdell; Joseph B Stanford; Tina Kold Jensen; Elizabeth Heger Boyle; Michael L Eisenberg; Paul J Turek; Rajeshwari Sundaram; Marie E Thoma; Germaine M Buck Louis Journal: Hum Reprod Date: 2017-03-01 Impact factor: 6.918
Authors: Heidi A Hanson; Erik N Mayer; Ross E Anderson; Kenneth I Aston; Douglas T Carrell; Justin Berger; William T Lowrance; Ken R Smith; James M Hotaling Journal: Hum Reprod Date: 2016-12-06 Impact factor: 6.918
Authors: Ross E Anderson; Heidi A Hanson; Diana Thai; Chong Zhang; Angela P Presson; Kenneth I Aston; Douglas T Carrell; Ken R Smith; James M Hotaling Journal: J Assist Reprod Genet Date: 2018-03-17 Impact factor: 3.412
Authors: Ross E Anderson; Heidi A Hanson; William T Lowrance; Jeffrey Redshaw; Siam Oottamasathien; Anthony Schaeffer; Erica Johnstone; Kenneth I Aston; Douglas T Carrell; Patrick Cartwright; Ken R Smith; James M Hotaling Journal: J Urol Date: 2017-01-26 Impact factor: 7.450
Authors: Nathan D Burke; Brett Nixon; Shaun D Roman; John E Schjenken; Jessica L H Walters; R John Aitken; Elizabeth G Bromfield Journal: Nat Rev Urol Date: 2022-09-13 Impact factor: 16.430